The kinetics of nucleated polymerizations at high concentrations: Amyloid fibril formation near and above the "supercritical concentration''

被引:174
作者
Powers, Evan T. [1 ]
Powers, David L.
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Clarkson Univ, Dept Math & Comp Sci, Potsdam, Germany
关键词
D O I
10.1529/biophysj.105.073767
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The formation of amyloid and other types of protein fibrils is thought to proceed by a nucleated polymerization mechanism. One of the most important features commonly associated with nucleated polymerizations is a strong dependence of the rate on the concentration. However, the dependence of fibril formation rates on concentration can weaken and nearly disappear as the concentration increases. Using numerical solutions to the rate equations for nucleated polymerization and analytical solutions to some limiting cases, we examine this phenomenon and show that it is caused by the concentration approaching and then exceeding the equilibrium constant for dissociation of monomers from species smaller than the nucleus, a quantity we have named the ''supercritical concentration''. When the concentration exceeds the supercritical concentration, the monomer, not the nucleus, is the highest-energy species on the fibril formation pathway, and the fibril formation reaction behaves initially like an irreversible polymerization. We also derive a relation that can be used in a straightforward method for determining the nucleus size and the supercritical concentration from experimental measurements of fibril formation rates.
引用
收藏
页码:122 / 132
页数:11
相关论文
共 52 条
[1]  
ANDREU JM, 1986, METHOD ENZYMOL, V130, P47
[2]  
ARVINTE T, 1993, J BIOL CHEM, V268, P6415
[3]  
BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.bb.14.060185.001023
[4]   KINETICS OF NUCLEATION-CONTROLLED POLYMERIZATION - A PERTURBATION TREATMENT FOR USE WITH A SECONDARY PATHWAY [J].
BISHOP, MF ;
FERRONE, FA .
BIOPHYSICAL JOURNAL, 1984, 46 (05) :631-644
[5]   Diseases of protein conformation:: what do in vitro experiments tell us about in vivo diseases? [J].
Buxbaum, JN .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (11) :585-592
[6]   Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation [J].
Chen, SM ;
Ferrone, FA ;
Wetzel, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11884-11889
[7]   Therapeutic approaches to protein-misfolding diseases [J].
Cohen, FE ;
Kelly, JW .
NATURE, 2003, 426 (6968) :905-909
[8]   Mechanism of prion propagation: Amyloid growth occurs by monomer addition [J].
Collins, SR ;
Douglass, A ;
Vale, RD ;
Weissman, JS .
PLOS BIOLOGY, 2004, 2 (10) :1582-1590
[9]   Protein folding and misfolding [J].
Dobson, CM .
NATURE, 2003, 426 (6968) :884-890
[10]   SOME THERMODYNAMIC ASPECTS OF AGGREGATION PHENOMENA WITH SPECIAL REFERENCE TO MICELLIZATION [J].
EVERETT, DH .
COLLOIDS AND SURFACES, 1986, 21 :41-53